- Israel Govt to grant funds to GE, Change & Medtronic
- Qatar Health Ministry recalls 7 pharma products
- Ieon-nanodrugs announces collaboration with Takeda
- Polares Medical announces closing of $25M financing
- FDA approves Calcitriol’s new contract manufacturing submission
- Cerecor expands leadership team
- Strengthen efforts to immunize 5 million unvaccinated children: WHO
- LeapFrog acquires majority stake in Ascent Meditech
- NewStem announces $4M seed financing
- Aeglea BioTherapeutics brings Dr. Bryan Lawlis on Board
- RGN-259 (Tβ4) better improves Dry Eye Syndrome
- New ALS therapy in clinical trials
- NCP invests in Firma Clinical Research
- Novotech partners with Asian Eye Institute
-
Pharma | 05 January 2018 | News
AstraZeneca collaborates with Myriad Genetics for cancer therapy
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its tes...Read more
Digital Health | 05 January 2018 | News
Microsoft partners with Adaptive Biotechnologies
The tech giant Microsoft is partnering with Seattle biotech company Adaptive Biotechnologies on a year-long pr...Read more
-
Japan | 17 July 2018 | News
Ieon-nanodrugs announces collaboration with Takeda
leon-nanodrugs GmbH is pleased to announce that its proprietary MicroJet Reactor nano-technology has been...Read more
-
Middle East countries | 17 July 2018 | News
NewStem announces $4M seed financing
NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemother...Read more
-
Middle East countries | 17 July 2018 | News
Israel Govt to grant funds to GE, Change & Medtronic
Israel's government will award grants to GE Health, Medtronic, and Change Healthcare to support the expansion ...Read more
-
Pharma | 04 January 2018 | News
Europe's biggest private biotech company raises $270 million
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to supp...Read more
ASEAN – Emerging hotspot for Big pharmas
ASEAN is growing, and growing with it is the region’s pharma sector. With growth in developed markets flattening, pharma industry is betting on lucrative ASEAN markets for profits. Think of Asia’s emerging markets and the instant names that appear are India and China. Undoubtedly, these are huge markets for the industry. But apart from these main markets, ASEAN’s emerging markets, with an annual growth rate of 11 per cent and huge untapped potential, provide a massive opportunity for big pharma to expand and grow in this region.
